HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months

被引:83
作者
Edghill, Emma L.
Dix, Rachel J.
Flanagan, Sarah E.
Bingley, Polly J.
Hattersley, Andrew T.
Ellard, Sian
Gillespie, Kathleen M.
机构
[1] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England
[2] Univ Bristol, Dept Clin Sci N Bristol, Bristol, Avon, England
基金
英国惠康基金;
关键词
D O I
10.2337/db06-0094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Children with permanent diabetes are usually assumed to have type 1 diabetes. It has recently been shown that there are genetic subgroups of diabetes that are often diagnosed during the neonatal period but may present later. A recent Italian study proposed that type I diabetes is rare before 6 months of age. We aimed to examine genetic susceptibility to type 1 diabetes in patients diagnosed with diabetes before the age of 2 years. We analyzed HLA class 11 genotypes, markers of autoimmune diabetes, in 187 children with permanent diabetes diagnosed at < 2 years of age. Of the 79 subjects diagnosed at < 6 months of age, 41% (95% CI 0.30-0.51) had type 1 diabetes-associated high-risk genotypes, a proportion similar to that in healthy population control subjects (44%, P = 0.56). This group included 32 patients with mutations in the KCNJ11 gene, which encodes Kir6.2 (44% high-risk HLA class 11 genotypes), and 47 in whom the etiology of diabetes was unknown (38% high-risk HLA class 11 genotypes). Of 108 patients diagnosed between 6 and 24 months of age, 93% (0.86-0.99) had high-risk HLA class 11 genotypes compared with 44% of the population control subjects (P < 0.0001). We conclude that infants diagnosed with diabetes before 6 months of age are unlikely to have autoimmune type 1 diabetes and are most likely to have a monogenic etiology.
引用
收藏
页码:1895 / 1898
页数:4
相关论文
共 22 条
  • [1] Prediction of IDDM in the general population - Strategies based on combinations of autoantibody markers
    Bingley, PJ
    Bonifacio, E
    Williams, AJK
    Genovese, S
    Bottazzo, GF
    Gale, EAM
    [J]. DIABETES, 1997, 46 (11) : 1701 - 1710
  • [2] DIABETES DIAGNOSED BEFORE THE AGE OF 2 YEARS - MORTALITY IN A BRITISH COHORT 8-17 YEARS AFTER ONSET
    BOTHA, JL
    PARKER, H
    RAYMOND, NT
    SWIFT, PGF
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1992, 21 (06) : 1132 - 1137
  • [3] High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation
    Codner, E
    Flanagan, S
    Ellard, S
    García, H
    Hattersley, AT
    [J]. DIABETES CARE, 2005, 28 (03) : 758 - 759
  • [4] Devendra Devasenan, 2003, Journal of Allergy and Clinical Immunology, V111, pS624
  • [5] Activating mutations in the KCNJ11 gene encoding the ATP-sensitive K+ channel subunit Kir 6.2 are rare in clinically defined type 1 diabetes diagnosed before 2 years
    Edghill, EL
    Gloyn, AL
    Gillespie, KM
    Lambert, AP
    Raymond, NT
    Swift, PG
    Ellard, S
    Gale, EAM
    Hattersley, AT
    [J]. DIABETES, 2004, 53 (11) : 2998 - 3001
  • [6] FLANAGAN SE, 2005, DIABETIC MED, V22, P10
  • [7] Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the β-cell potassium adenosine triphosphate channel
    Gloyn, AL
    Cummings, EA
    Edghill, EL
    Harries, LW
    Scott, R
    Costa, T
    Temple, IK
    Hattersley, AT
    Ellard, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) : 3932 - 3935
  • [8] Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes
    Gloyn, AL
    Pearson, ER
    Antcliff, JF
    Proks, P
    Bruining, GJ
    Slingerland, AS
    Howard, N
    Srinivasan, S
    Silva, JMCL
    Molnes, J
    Edghill, EL
    Frayling, TM
    Temple, IK
    Mackay, D
    Shield, JPH
    Sumnik, Z
    van Rhijn, A
    Wales, JKH
    Clark, P
    Gorman, S
    Aisenberg, J
    Ellard, S
    Njolstad, PR
    Ashcroft, FM
    Hattersley, AT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18) : 1838 - 1849
  • [9] Activating mutations in Kir6.2 and neonatal diabetes - New clinical syndromes, new scientific insights, and new therapy
    Hattersley, AT
    Ashcroft, FM
    [J]. DIABETES, 2005, 54 (09) : 2503 - 2513
  • [10] The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease
    Hattersley, AT
    Tooke, JE
    [J]. LANCET, 1999, 353 (9166) : 1789 - 1792